Clinical trial · Observational
Patient and Provider Perspectives on Genetic Risk Profiling
Exploring the Patient and Provider Perspectives on the Utility of Genetic Risk Profiling for Prostate Cancer in Routine Clinical Practice
NCT07741929CI-TRIAL-00120236PPPrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Qualitative interview | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patient participants
- description
- Diverse cohort of patients who have undergone genetic risk profiling and have received their results
- interventionNames
- Other: Qualitative interview
- label
- Provider participants
- description
- Healthcare providers who have delivered genetic risk profiling results to patients
- interventionNames
- Other: Qualitative interview
Primary outcomes (1)
- measure
- Data pertaining to the experiences and perspectives of healthcare providers and patients regarding the clinical utility of genetic risk profiling in routine clinical practice, using a qualitative (interview) thematic analysis approach.
- timeFrame
- January 2026 to August 2027
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Individuals assigned male at birth who are aged 18 and over and who have capacity to consent * Patients who have undergone genetic risk profiling for prostate cancer and have received their results * Individuals from diverse backgrounds (age, ethnicity, risk status, etc) * Healthcare providers who have delivered a genetic risk profiling result for prostate cancer Exclusion Criteria: * Individuals who lack capacity to consent * Individuals deemed unsuitable to recruit based on their poor performance status or current medical condition
References
Publications (0)
Data not yet available
No reference posted for this study.